Vitamin D receptor 3'-untranslated region polymorphisms: Lack of effect on mRNA stability

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1453, Issue 3, 1999, Pages 311-320

  Durrin, Linda K ^a   Haile, Robert W ^a   Ingles, Sue A ^a   Coetzee, Gerhard A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Message half life; Polymorphism; Vitamin D receptor

Indexed keywords

MESSENGER RNA; VITAMIN D RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HALF LIFE TIME; HUMAN; HUMAN CELL; LEUKOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER;

3' UNTRANSLATED REGIONS; 3T3 CELLS; ALLELES; ANIMALS; HUMANS; LEUKOCYTES; MALE; MICE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RISK FACTORS; RNA, MESSENGER; VARIATION (GENETICS);

EID: 0032970264     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(99)00007-1     Document Type: Article

References (22)

1. Miyamoto K.-I., Kesterson R.A., Yamamoto H., Taketani Y., Nishiwaki E., Tatsumi S., Inoue Y., Morita K., Takeda E., Pike J.W. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 11:1997;1165-1179.
2. Morrison N.A., Yeoman R., Kelly P.J., Eisman J.A. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor polymorphisms and circulating osteocalcin. Proc. Natl. Acad. Sci. USA. 89:1992;6665-6669.
3. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature. 367:1994;284-287.
4. Taylor J.A., Hirvonen A., Watson M., Pittman G., Mohler J.L., Bell D.A. Association of prostate cancer with vitamin D receptor gene polymorphisms. Cancer Res. 56:1996;4108-4110.
5. Ingles S.A., Ross R.K., Yu M.C., Irvine R.A., La Pera G., Haile R.W., Coetzee G.A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer Inst. 89:1997;166-170.
6. Ingles S.A., Coetzee G.A., Ross R.K., Henderson B.E., Kolonel L.N., Crocitto L., Wang W., Haile R.W. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res. 58:1998;1620-1623.
7. Feldman D. Androgen and vitamin D receptor gene polymorphisms: the long and the short of prostate cancer risk. J. Natl. Cancer Inst. 89:1997;109-111.
8. Ingles S.A., Haile R.W., Henderson B.E., Kolonel L.N., Nakaichi G., Shi C.-Y., Yu M.C., Ross R.K., Coetzee G.A. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol. Biomarkers Prev. 6:1997;93-98.
9. Verbeek W., Gombart A.F., Shiohara M., Campbell M., Koeffler H.P. Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism. Biochem. Biophys. Res. Commun. 238:1997;77-80.
10. Mocharla H., Butch A.W., Pappas A.A., Flick J.T., Weinstein R.S., De Togni P., Jilka R.L., Roberson P.K., Parfitt A.M., Manolagas S.C. Quantification of vitamin D receptor mRNA by competing polymerase chain reaction in PBMC: lack of correspondence with common allelic variants. J. Bone Miner. Res. 12:1997;726-733.
11. Carling T., Rastad J., Akerstrom G., Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J. Clin. Endocrinol. Metab. 83:1998;2255-2259.
12. Gross C., Musiol I.M., Eccleshall T.R., Malloy P.J., Feldman D. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts. Biochem. Biophys. Res. Commun. 242:1998;467-473.
13. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59:1995;423-450.
14. Gross C., Eccleshall T.R., Malloy P.J., Villa M.L., Marcus R., Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J. Bone Miner. Res. 11:1996;1850-1855.
15. Arai H., Miyamoto K.-I., Taketani Y., Yamamoto H., Iemori Y., Morita K., Tanai T., Nishisho T., Mori S., Takeda E. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res. 12:1997;915-921.
16. Shyu A.-B., Greenberg M.E., Belasco J.G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:1989;60-72.
17. Lagnado C.A., Brown C.Y., Goodall G.J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:1994;7984-7995.
18. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
19. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3294-3298.
20. Russell J.E., Liebhaber S.A. The stability of human β-globin mRNA is dependent on structural determinants positioned within its 3′-untranslated region. Blood. 87:1996;5314-5323.
21. Levy A.P., Levy N.S., Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:1996;2746-2753.
22. McGowan K.M., Police S., Winslow J.B., Pekala P.H. Tumor necrosis factor-α regulation of glucose transporter (GLUT1) mRNA turnover: contribution of the 3′-untranslated region of the GLUT1 message. J. Biol. Chem. 272:1997;1331-1337.